Literature DB >> 9915040

Report from Working Group 3 (the Czech Republic, Denmark, Finland, Norway, The Netherlands, Slovakia, Sweden and the UK).

S Iwarson1.   

Abstract

The Czech Republic, Denmark, Finland, Norway, the Netherlands, Slovakia, Sweden and the UK all have very low HBsAg carrier rates; in the Scandinavian countries, for instance, carrier rates are on the order of 0.05%. Most countries in this group are unconvinced that the carrier rates and the burden of disease caused by new hepatitis infections warrant the expense of universal childhood immunization. In Scandinavia and the UK hepatitis B prevention programmes are based on immunization of high-risk groups. In Scandinavia (excepting Denmark), the UK and the Netherlands, pregnant women are screened and newborns of carrier mothers vaccinated. Only the Czech Republic and Slovakia--both of which now employ high-risk group strategies of hepatitis B prevention--have expressed interest in implementing programmes of universal hepatitis B vaccination of infants and/or adolescents.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9915040     DOI: 10.1016/s0264-410x(98)00299-0

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

Review 1.  Screening in liver disease.

Authors:  Paolo Del Poggio; Marzio Mazzoleni
Journal:  World J Gastroenterol       Date:  2006-09-07       Impact factor: 5.742

2.  Epidemiology of acute and chronic hepatitis B virus infection in Norway, 1992-2009.

Authors:  Gražina Rimšelienė; Øivind Nilsen; Hilde Kløvstad; Hans Blystad; Preben Aavitsland
Journal:  BMC Infect Dis       Date:  2011-05-26       Impact factor: 3.090

3.  Time trends in socioeconomic differences in incidence rates of cancers of gastro-intestinal tract in Finland.

Authors:  Elisabete Weiderpass; Eero Pukkala
Journal:  BMC Gastroenterol       Date:  2006-12-04       Impact factor: 3.067

Review 4.  Viruses and human cancer.

Authors:  John B Liao
Journal:  Yale J Biol Med       Date:  2006-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.